Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice

Journal of Clinical Investigation

Volumn 118, Issue 9, 2008, Pages 3012-3024

  Gong, Yanqing ^a   Hart, Erika ^a   Shchurin, Aleksey ^a,b   Hoover Plow, Jane ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Oakwood Healthcare Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; GELATINASE B; PLASMINOGEN; THIOGLYCOLIC ACID;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXTRACELLULAR MATRIX; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HETEROZYGOTE; INFLAMMATION; LAMININ; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PLASMINOGEN; PROTEOGLYCANS;

EID: 51349089060     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32750     Document Type: Article

References (56)

1. Stoll, G., and Bendszus, M. 2006. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 37:1923-1932.
2. Worthylake, R.A., and Burridge, K. 2001. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr. Opin. Cell Biol. 13:569-577.
3. Page-McCaw, A., Ewald, A.J., and Werb, Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8:221-233.
4. Stamenkovic, I. 2003. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 200:448-464.
5. Anidjar, S., Dobrin, P.B., Eichorst, M., Graham, G.P., and Chejfec, G. 1992. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J. Vasc. Surg. 16:139-147.
6. Shimizu, K., Mitchell, R.N., and Libby, P. 2006. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 26:987-994.
7. Luttun, A., and Carmeliet, P. 2001. Genetic studies on the role of proteinases and growth factors in atherosclerosis and aneurysm formation. Ann. N. Y. Acad. Sci. 947:124-132.
8. Carmeliet, P. 2000. Proteinases in cardiovascular aneurysms and rupture: targets for therapy? J. Clin. Invest. 105:1519-1520.
9. Zhang, L., et al. 2002. Plasminogen has a broad extrahepatic distribution. Thromb. Haemost. 87:493-501.
10. Wang, N., Zhang, L., Miles, L., and Hoover-Plow, J. 2004. Plasminogen regulates pro-opiomelanocortin processing. J. Thromb. Haemost. 2:785-796.
11. Busuttil, S.J., et al. 2004. A central role for plasminogen in the inflammatory response to biomaterials. J. Thromb. Haemost. 2:1798-1805.
12. Ploplis, V.A., French, E.L., Carmeliet, P., Collen, D., and Plow, E.F. 1998. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood. 91:2005-2009.
13. Ling, C., et al. 2006. Disruption of tissue plasminogen activator gene reduces macrophage migration. Biochem. Biophys. Res. Commun. 349:906-912.
14. Liu, Z., et al. 2005. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest. 115:879-887.
15. Moons, L., et al. 1998. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J. Clin. Invest. 102:1788-1797.
16. Creemers, E., et al. 2000. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am. J. Pathol. 156:1865-1873.
17. Carmeliet, P., et al. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-444.
18. Deng, G.G., et al. 2003. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ. Res. 92:510-517.
19. Wang, Y.X., et al. 2001. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am. J. Pathol. 159:1455-1464.
20. Qian, H.S., et al. 2007. Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice. Gene Ther. 15:224-232.
21. Moser, T.L., Enghild, J.J., Pizzo, S.V., and Stack, M.S. 1993. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. J. Biol. Chem. 268:18917-18923.
22. Lijnen, H.R. 2001. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb. Haemost. 86:324-333.
23. Melnicoff, M.J., Horan, P.K., and Morahan, P.S. 1989. Kinetics of changes in peritoneal cell populations following acute inflammation. Cell. Immunol. 118:178-191.
24. van Furth, R., Diesselhoff-Den Dulk, M.M.C., and Mattie, H. 1973. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J. Exp. Med. 138:1314-1330.
25. Margetts, P.J., et al. 2002. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am. J. Pathol. 160:2285-2294.
26. Nagy, J.A. 1996. Peritoneal membrane morphology and function. Kidney Int. Suppl. 56:S2-S11.
27. Lijnen, H.R., et al. 1998. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler. Thromb. Vasc. Biol. 18:1035-1045.
28. Ramos-DeSimone, N., et al. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274:13066-13076.
29. Toth, M., et al. 2003. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem. Biophys. Res. Commun. 308:386-395.
30. Masure, S., Nys, G., Fiten, P., Van, D.J., and Opdenakker, G. 1993. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. Eur. J. Biochem. 218:129-141.
31. Shah, P.K. 1997. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 96:2115-2117.
32. Basalyga, D.M., et al. 2004. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 110:3480-3487.
33. Longo, G.M., et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110:625-632.
34. Yoshimura, K., et al. 2005. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 11:1330-1338.
35. Legrand, C., et al. 1999. Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling. J. Cell Biol. 146:517-529.
36. Johnson, C., and Galis, Z.S. 2004. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler. Thromb. Vasc. Biol. 24:54-60.
37. Bergers, G., et al. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:737-744.
38. Yasuda, T., and Poole, A.R. 2002. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum. 46:138-148.
39. Weathington, N.M., et al. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12:317-323.
40. Van den Steen, P.E., et al. 2003. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270:3739-3749.
41. Liu, K., et al. 2006. Successful ovulation in plasminogen-deficient mice treated with the broad-spectrum matrix metalloproteinase inhibitor galardin. Dev. Biol. 295:615-622.
42. Renckens, R., et al. 2006. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J. Immunol. 177:1189-1196.
43. Deindl, E., et al. 2003. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. FASEB J. 17:1174-1176.
44. Yang, Y.H., Carmeliet, P., and Hamilton, J.A. 2001. Tissue-type plasminogen activator deficiency exacerbates arthritis. J. Immunol. 167:1047-1052.
45. Carmeliet, P., et al. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:419-424.
46. Hoover-Plow, J.L., et al. 2008. Strain and model dependent differences in inflammatory cell recruitment in mice. Inflamm. Res. In press.
47. Choi, E.T., et al. 2005. Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injury-induced accelerated atherosclerotic plaque development in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25:1020-1025.
48. Pyo, R., et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105:1641-1649.
49. Shi, W., et al. 2003. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23:1901-1906.
50. Thompson, R.W., et al. 2006. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann. N. Y. Acad. Sci. 1085:59-73.
51. Ducharme, A., et al. 2000. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106:55-62.
52. Sha, J., et al. 2005. Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. J. Thromb. Haemost. 3:2281-2289.
53. Chiou, A.C., Chiu, B., and Pearce, W.H. 2001. Murine aortic aneurysm produced by periarterial application of calcium chloride. J. Surg. Res. 99:371-376.
54. Lijnen, H.R., Wagner, E.F., and Collen, D. 1997. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivtion of fibrinolytic genes. Thromb. Haemost. 77:362-367.
55. Davis, V., et al. 1998. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18:1625-1633.
56. Goldberg, G.I., Strongin, A., Collier, I.E., Genrich, L.T., and Marmer, B.L. 1992. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267:4583-4591.